“Blood Transfusion Diagnostics Market” report offers an extensive thorough analysis of the market via in-depth qualitative observations, historical data, and identifiable projections about market size and developing business sector habits.
Blood transfusion is a process that ensures safe intravenous transfer of blood or blood products. The process can also allow replacement of blood. Various blood components like red blood cells, white blood cells, platelets, clotting factors and plasma can also be transfused. These components find great application in hospitals during emergencies. The global blood transfusion diagnostics has been predicted to grow up to USD 2.45 billion in 2023 with a CAGR of 8.2% over the review period of 2017-2023. Market Research Future (MRFR) claims that the global market has the potential to surpass market predictions and ensure better growth for itself.
Various factors, like technological advancements, safe transfer procedures, various chronic diseases, and others can impact the global market. But the process requires proper screening to prohibit any unwanted disease to get transferred. Governments have introduced stringent measures to prohibit such cases from having. Hike in the campaign to promote the process can also be suggested as a good market backup.
Get Exclusive Sample Copy of “Blood Transfusion Diagnostics Market” Report @ https://www.marketresearchfuture.com/sample_request/1126
In June 2019, Dubai Health Authority (DHA) announced the launch of its blood donation campaign, ‘Be the Hero … Save Lives’ for encouraging donators and creating awareness.
In June 2019, The American Chamber of Commerce in Việt Nam (AmCham Vietnam) collaborated with HCM City Institute of Hematology, and Blood Transfusion organized a blood donation campaign to celebrate the World’s Blood Donor Day on 14th of the month.
In February 2019, a two year old in the Tamil Nadu state of India was alleged to have contracted HIV from a blood transfusion. Further enquiries cleared the hospital staff of any wrongdoing, as the source of the HIV was ascertained to be something other than the transfusion. Such incidents reveal the need for strong blood transfusion diagnostics infrastructure, especially in emerging countries.
In January 2019, a leader in transfusion and transplantation diagnostics, Immucor, Inc., has announced that it has received approval from Health Canada for its next-gen fully automated Echo® instrument, Echo LumenaTM.
Key Players – Global Blood Transfusion Diagnostics Market
Prominent companies taking part in the global blood transfusion diagnostics market are Roche Diagnostics (Switzerland), Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Immucor (U.S), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Ortho Clinical Diagnostics (U.S), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Beckman Coulter (U.S), BAG healthcare (Germany), DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S Abbott Diagnostics (U.S),), Biokit (Spain). MRFR profiled these companies to have their market analyzed in a better way.
Segments – Global Blood Transfusion Diagnostics Market
The global blood transfusion diagnostics market report has been segmented by MRFR for a better understanding of the factors that can impact the market in the coming years. This segmentation has better insights to provide a better direction for the coming years.
Based on the blood product, the global blood transfusion diagnostics market can be segmented into red blood cells, platelets, plasma, albumin, immunoglobulin preparations and other products.
Based on the technology, the blood transfusion diagnostics market comprises western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test and other technologies. The ELISA segment comprises fluorescence immunoassays (FIA), chemiluminescence immunoassay (CLIA), and colorimetric immunoassay (CI). The Nucleic Acid Amplification segment includes Thermomechanical analysis (TMA) and real-time PCR.
Based on the end-users, the blood transfusion diagnostics market can be segmented into hospitals, clinics, blood banks, and laboratories. The hospitals segment has substantial market coverage as a lot of people opt for this option to undergo the process.
Regional Analysis – Global Blood Transfusion Diagnostics Market
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions that have been included in the geographical reading of the global blood transfusion diagnostics market. The process eases the identification steps for the growth pockets.
The Americas is known for their high impact on the global blood transfusion diagnostics market. Several factors are working in favor of the growth of the regional blood transfusion diagnostics market, among them increasing adoption of nucleic acid implication test of diagnosis, automation of blood banks and stringent rules for storage & transfusion of blood play integral roles. The growth is exceptionally well in North America where the presence of the U.S. and Canada are playing important roles.
Europe’s growth has base in features that are quite similar to that of the Americas. The market is witnessing substantial hike in the demand for improved diagnostics test, availability of the skilled healthcare professionals and better collaboration with NGO’s, which can be accredited for the growth of the regional market. The APAC market is all set to get the highest growth during the forecast period where Japan would posit itself as the largest market. The market is also expecting strong traction from countries like China and India. These two countries are showing substantial integration of the latest technologies that can impact the regional market and influence their individual outcome.
Browse Complete “Blood Transfusion Diagnostics Market” Report @ https://www.marketresearchfuture.com/reports/blood-transfusion-diagnostics-market-1126
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312